NCT02801903View on ClinicalTrials.gov

Pharmacokinetics of Topical SB204 in Adolescents With Acne Vulgaris

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 7, 2016

Primary Completion Date

August 31, 2016

Study Completion Date

August 25, 2016

Conditions
Acne Vulgaris
Interventions
DRUG

SB204 4%

Topically Once Daily (AM)

Trial Locations (1)

78759

WCCT #1, Austin

Sponsors

Collaborators (1)

WCCT Global
All Listed Sponsors
collaborator

WCCT Global

INDUSTRY

lead

Novan, Inc.

INDUSTRY

NCT02801903 - Pharmacokinetics of Topical SB204 in Adolescents With Acne Vulgaris | Biotech Hunter | Biotech Hunter